Trend in deposit maturity profile

Similar documents
ICICI BANK PRICE: RS.315 TARGET PRICE: RS.400 FY17E P/E: 12.3X, P/ABV: 1.8X

ICICI BANK PRICE: RS.277 TARGET PRICE: RS.400 FY17E P/E: 11.2X, P/ABV: 1.7X. Q2FY16 results: Earnings in line; slippages remained elevated

(Rs bn) < 1 Yr Share 1 Yr - 3Yr Share 3Yr - 5Yr Share > 5 Yr Share Total

AXIS BANK PRICE: RS.581 TARGET PRICE: RS.685 FY17E P/E: 13.7X, P/ABV: 2.5X

Source: Company, Kotak Securities - Private Client Research

AXIS BANK PRICE: RS.1422 TARGET PRICE: RS.1535 FY14E P/E: 10.0X, P/ABV: 1.9X

AXIS BANK PRICE: RS.854

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `279 `348. 2QFY2016 Result Update Banking. 3-year price chart. Key financials (Standalone)

Punjab National Bank

Punjab National Bank

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

Recommendation BUY Snapshot CMP (01/08/2011) Rs. 85 Target Rs. 129

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

ICICI Group: Strategy & Performance. Motilal Oswal Conference September 2, 2013

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

State Bank of India. Strong operating performance. Source: Company Data; PL Research

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

ICICI Group: Performance & Strategy. May 2015

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

FY17 FY18 FY19E FY20E

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. GEOJIT BNP PARIBAS Research. CMP Rs259 TARGET Rs284 RETURN 10% 22 nd August 2016

Page. ICICI Bank Ltd. RESULT UPDATE 31 st July, 2017

ICICI Bank. Source: Company Data; PL Research

Kotak Mahindra Bank. Source: Company Data; PL Research. PE (x) Net dividend yield (%) Source: Bloomberg

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

DCB Bank Ltd. 1 P a g e

93,707 77,814 90, NIM

Bank of Baroda (BOB)

9,251 7,812 8, NIM

Axis Bank Ltd. For private circulation only. Volume No.. III Issue No October 08, 2018

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

systemic liquidity. Alpesh Mehta Sohail Halai

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

ICICI Bank BUY RESULTS REVIEW 4QFY17 04 MAY Highlights of the quarter. CMP (as on 3 May 2017) Rs 273 Target Price Rs 345

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

HDFC Bank Ltd. BUY. Investment Rationale. July 2, Volume No.. 1 Issue No. 28

BANK OF BARODA Hold POST RESULT NOTE

Performance and Outlook

ICICI Group: Performance & Strategy. November 2015

Key estimate revision. Financial summary. Year

State Bank of India (SBIN IN)

South Indian Bank Ltd.

9,807 8,007 9, NIM

DCB Bank Ltd. 18 th August, 2014 BUY

Key estimate revision. Financial summary. Year

Economy News. Corporate News NOVEMBER 1, 2011

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

IndusInd Bank. CMP: INR345 TP: INR419 Buy

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Union Bank of India NEUTRAL. Performance Highlights CMP. `393 Target Price - 2QFY2011 Result Update Banking. Investment Period -

Page. ICICI Bank Ltd. RESULT UPDATE 30 th October, 2017

Kotak Mahindra Bank. Performance on track, Strong guidance for the second half. Q2FY17 Result Update

Punjab National Bank NEUTRAL. Performance Highlights CMP. `134 Target Price - 2QFY2016 Result Update Banking November 13, Investment Period -

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Punjab National Bank

HDFC Bank ACCUMULATE. Performance Highlights. CMP `2,348 Target Price `2,671. 4QFY2011 Result Update Banking. Key financials

State Bank of India (SBI)

STATE BANK OF INDIA RESEARCH

Financial summary. Year

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

ICICI Group: Strategy & Performance

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

HDFC Bank (HDFCB IN)

Axis Bank Banking. HOLD Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

DENA BANK Value Play; Risk-Reward favorable

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

Yes Bank BUY. CMP Target Price `380 `435. Initiating Coverage Banking. Growth affirmed. 3-year price chart. Key Financials (Standalone)

ICICI Bank BUY. Performance Highlights CMP. `928 Target Price `1,169. 1QFY2013 Result Update Banking. Investment Period 12 Months

DCB Bank. More hits, fewer misses BUY RESULTS REVIEW 3QFY17 17 JAN Highlights of the quarter. CMP (as on 16 Jan 2017) Rs 121 Target Price Rs 143

Dewan Housing Finance

Bank of Baroda. Source: Company Data; PL Research

Kotak Mahindra Bank. Healthy operating performance. Source: Company Data; PL Research

ICICI Group: Strategy & Performance. February 2010

RBL Bank BUY. CMP Target Price `573 `690. Quick take BANK. January 7, year price chart

Syndicate Bank NEUTRAL. Performance Highlights CMP. `81 Target Price - 2QFY2014 Result Update Banking. Investment Period -

Valuation and Outlook. Growth (%) PAT (Rs cr)

HDFC Bank. Remains strong in all areas. Source: Company Data; PL Research

Jammu and Kashmir Bank

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

Punjab National Bank. CMP: INR768 TP: INR963 Buy

ICICI Bank. Source: Company Data; PL Research

M&M Financial Services (MMFSL)

LIC Housing Finance. Source: Company Data; PL Research

PTC India Financial Services

Performance and Outlook. November 2016

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

ICICI Bank (ICICIBC IN) Strong improvement in asset quality

Punjab National Bank

Transcription:

COMPANY UPDATE Saday Sinha saday.sinha@kotak.com +91 22 6621 6312 ICICI BANK PRICE: RS.1571 RECOMMENDATION: BUY TARGET PRICE: RS.1821 FY16E P/E: 13.5X, P/ABV: 2.1X ICICI bank has continued to demonstrate its prowess in improving ALM, asset quality, funding mix along with conserving capital. Its favorable ALM would support healthy margin which in-turn aid in robust core performance. Its asset quality pressure to ease, we expect fear of exposure to highly leveraged entities to abate as many corporate continue to deleverage through asset sale or fresh equity issuances. We believe incremental stress built-up which peaked during FY14 is likely to be lower during FY15. Stock trades reasonable (1.7x FY16E ABV) post stripping the value for subsidiaries. We believe management focus on stable growth with improving structural profitability would continue and hence, we reiterate BUY on the stock with revised TP of Rs.1821 (Rs.1660 earlier) using SOTP method, where the value of its standalone business comes to Rs.1501 (2.0x FY16E ABV) and the value of subsidiaries at Rs.320 (holding company discount: 20% to the fair value of its subsidiaries at Rs.400). Healthy NIM to aid in robust core performance; favorable ALM bodes well for the stock during downward trending interest rate cycle. We expect ICICI bank's NII to grow 16.2% CAGR during FY14-16E as compared to 14.5% CAGR reported during FY09-14 mainly aided by healthy margin expansion. Over the years, strong liability franchise has helped ICICI bank to contain its funding costs. Even during previous quarter (Q1FY15), cost of funds declined to 6.19% (11bps YoY) while yield on asset remained stable YoY, resulting into 13bps of NIM (3.40% in Q1FY15). We believe with favorable ALM (share of deposits in <1 Yr bucket stands at 36.9%, while share of advances in the same bucket stands at 26.3% in FY14), ICICI bank is likely to report healthy NIM (3.35%/3.41% in FY15/16E) during downward trending interest rate cycle. Trend in deposit maturity profile Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client Group. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Institutional Equities Research Group of Kotak Securities Limited. Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 2

Trend in advances maturity profile Liability franchise is likely to remain one of the best in the industry; healthy organic growth in retail segment is likely to continue in near term. We believe leadership in technology innovation is likely to support new customer acquisition as well as getting larger wallet-share from the existing customers. Its liability franchise is likely to remain one of the best in the industry supported by growing customer base. ICICI bank has consistently demonstrated its prowess in sustaining/improving CASA share during previous several quarters, when banking system as a whole was witnessing migration away from low cost deposits. Trend in Deposit growth Q1FY13 Q2FY13 Q3FY13 Q4FY13 Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 Deposits (bn) 2,677.9 2,814.4 2,864.2 2,926.1 2,911.9 3,090.5 3,169.7 3,319.1 3,357.7 Saving deposits 779.2 806.2 814.6 856.5 888.5 935.4 957.2 991.3 1,027.4 Current deposits 307.5 338.0 356.7 369.3 369.8 403.7 414.4 432.5 416.8 CASA 1,086.8 1,144.2 1,171.4 1,225.8 1,258.3 1,339.1 1,371.7 1,423.8 1,444.1 Term deposits 1,591.2 1,670.2 1,692.8 1,700.4 1,653.5 1,751.4 1,798.0 1,895.3 1,913.5 CASA (%) 40.6% 40.7% 40.9% 41.9% 43.2% 43.3% 43.3% 42.9% 43.0% We are of the view that ICICI bank with strong capitalization (CAR at 17%) and healthy traction in CASA deposits, would support 18-19% growth in domestic loan book. In near-term, we expect healthy organic growth in retail segment is likely to continue, while SME and domestic corporate books are likely to witness calibrated growth. During recent quarters, strong retail asset disbursements has aided in improving the share of retail business while domestic corporate and SME segments have seen secular decline. Strong growth in retail portfolio has been largely contributed by housing, auto and PL segments while management has continued with the calibrated strategy on CV portfolio which continued to decline on back of run-down of bought loan portfolio. Break-up of advances (New Classification) (%) Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 Retail Business 36.0 36.2 36.7 39.0 39.6 Domestic Corporate (includes builder finance) 32.5 32.6 31.5 30.1 30.4 SME 4.6 4.6 4.3 4.4 4.4 Overseas Branches 26.9 26.6 27.5 26.5 25.6 Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 3

Trend in retail loan book (Rs bn) Q1FY13 Q2FY13 Q3FY13 Q4FY13 Q1FY14 Q2 FY14 Q3 FY14 Q4 FY14 Q1 FY15 Total retai advances 964.0 963.0 1000.8 1074.0 1085.0 1151.0 1222.0 1320.0 1372.0 Vehicle Loans 258.4 257.1 251.2 258.8 246.3 255.5 259.1 275.9 278.5 Auto 90.6 96.3 100.1 109.5 110.7 120.9 134.4 151.8 161.9 CV 167.7 160.8 151.1 149.3 135.6 134.7 124.6 124.1 116.6 Housing 498.4 512.3 541.4 575.7 595.7 630.7 666.0 706.2 742.3 Business Banking 70.4 60.7 56.0 63.4 62.9 70.2 72.1 79.2 76.8 PL 9.6 8.7 11.0 16.1 18.4 24.2 30.6 39.6 46.6 Credit Cards 25.1 26.0 28.0 26.9 30.4 31.1 31.8 33.0 35.7 Others 102.2 98.2 113.1 132.1 131.3 139.3 162.5 186.1 192.1 The management has maintained its guidance of growing domestic loan book by few percentages (200-300bps) higher than the system on back of strong growth in retail book. They also indicated that domestic corporate book as well as overseas book is likely to witness calibrated approach, going forward, in the prevailing adverse macro environment. Asset quality pressure to ease; management's reiterated guidance of lower impairment during FY15 provides comfort. Street has been apprehensive about the ICICI's exposure to highly leveraged entities. However, we expect this fear to abate as many corporate continue to deleverage through asset sale or fresh equity issuances. We believe incremental stress built-up which peaked during FY14 is likely to be lower during FY15. During Q1FY15, we saw fresh loan impairment (gross slippage + new restructuring) coming at lower level (Rs.25.9 bn; 3.1% annualized) as against the run rate of Rs.33-34 bn seen during previous two quarters. Gross slippage during past few quarters has come primarily from SME as well as mid-size corporate segments. Trends in NPAs (Rs bn) Q1 FY14 Q2 FY14 Q3 FY14 Q4 FY14 Q1 FY15 Gross NPAs 100.6 100.8 104.5 105.5 110.0 Gross NPAs (%) 2.76% 2.68% 2.66% 2.56% 2.69% Net NPAs 24.7 27.1 31.2 33.0 34.7 Net NPAs (%) 0.69% 0.73% 0.81% 0.82% 0.87% Cumulative Provisions 75.9 73.7 73.3 72.5 75.3 Outstanding Std assets provisions 16.07 17.55 18.49 19.32 20.36 Provision Coverage Ratio (%) 75.4% 73.1% 70.0% 68.6% 68.4% Movement of NPA (Rs Bn) Q1 FY14 Q2 FY14 Q3 FY14 Q4 FY14 Q1 FY15 Opening balance 96.5 100.6 100.8 104.5 105.5 Slippage 11.2 11.5 12.3 12.4 12.0 Upgrade + Recovery 3.1 5.7 3.6 4.2 3.6 W/O & sale 4.0 5.6 5.0 7.2 3.9 Closing balance 100.6 100.8 104.5 105.5 110.0 Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 4

Its outstanding restructured book stands comfortable at Rs.112.7 bn (3.2% of advances) vis-à-vis industry average with relatively thin restructuring pipeline (Rs.15 bn as on Q1FY15). The share of retail portfolio in GNPA has fallen from 54% in Q1FY14 to 34% in Q1FY15, on back of fresh delinquencies coming primarily from SMEs and mid corporate. Trends in NPLs Rs. Bn Q1 FY14 Q2 FY14 Q3 FY14 Q4 FY14 Q1 FY15 Retail - Gross NPA 54.1 49.1 44.4 41.2 37.9 Corporate - Gross NPA 46.5 51.7 60.1 64.4 72.1 Retail - Net NPA 7.8 7.6 7.9 8.2 8.5 Corporate - Net NPA 17.0 19.5 23.3 24.8 26.3 ICICI bank has been performing better on the credit costs front - during Q1FY15, credit cost came at ~86bps, marginally better than the management full year guidance of 90bps (FY15), which also includes 10bps on account of provision on unhedged forex exposure. Valuation and Recommendation At CMP, stock trades reasonable at 13.5x its FY16E earnings and 2.1x its FY16E ABV (10.8x and 1.7x, respectively, after stripping the value for subsidiaries). We have tweaked the earnings estimates for FY15/16E and expect net income to grow 16.9% CAGR during FY14-16E. We opine that bank would continue its focus on liability franchise (CASA mix) and profitability (RoE is likely to improve to 16% levels during next 2 years with increase in leverage). We believe healthy NIM and moderate rise in opex is likely to provide sufficient cushion to its earnings profile with marginal higher credit costs in FY15. We also believe this is manageable given its healthy coverage ratio (68.4% in Q1FY15), providing sufficient cushion to its future earnings. Sum of Parts Valuation Basis Multiple Year Value / Share Core Banking Business (Standalone) ABV 2.0 FY16 1,501 Overseas Banking Subsidiaries ABV 1.0 FY16 96 Life Insurance Business EV + NBAP 12 FY16 140 Non-Life Insurance PAT 10 FY16 48 ICICI Securities PAT 10 FY16 21 ICICI PD Business PAT 10 FY16 21 sasset Management AUM 5% FY16 31 Private Equity AUM 10% FY16 11 Home Finance ABV 2.0 FY16 30 Total Value of subsidiaries 400 20% discounted value 320 Total Value 1,821 Source: Kotak Securities - Private Client Research We reiterate BUY on ICICI Bank with a price target of Rs.1821 We opine that management focus on stable growth with improving structural profitability continues which reinforces our existing positive outlook on the stock. We reiterate BUY on the stock with revised TP of Rs.1821 (Rs.1660 earlier) using SOTP method, where the value of its standalone business comes to Rs.1501 (2.0x FY16E ABV) and the value of subsidiaries at Rs.320 (holding company discount: 20% to the fair value of its subsidiaries at Rs.400). Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 5

Key data (Rs. bn) FY13 FY14 FY15E FY16E Interest income 400.8 441.8 500.3 575.0 Interest expense 262.1 277.0 310.6 352.4 Net interest income 138.7 164.8 189.7 222.5 Growth (%) 29.2% 18.8% 15.1% 17.3% Other income 83.5 104.3 118.1 133.8 Gross profit 132.0 165.9 190.8 222.4 Net profit 83.3 98.1 113.3 134.1 Growth (%) 28.8% 17.8% 15.5% 18.4% Gross NPA (%) 3.3 3.1 3.0 2.8 Net NPA (%) 0.8 1.0 1.0 0.9 Net interest margin (%) 3.0 3.2 3.3 3.4 CAR (%) 18.7 17.7 20.3 19.6 RoE (%) 13.1 14.0 14.7 15.6 RoA (%) 1.6 1.7 1.8 1.9 Dividend per share (Rs.) 20.0 23.0 25.0 27.0 EPS (Rs) 72.2 85.0 98.1 116.1 Adjusted BVPS (Rs) 558.8 605.2 667.7 750.6 P/E (x) 21.8 18.5 16.0 13.5 P/ABV (x) 2.8 2.6 2.4 2.1 Source: Kotak Securities - Private Client Research Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 6